Sylvie Sablayrolles

Protease-Activated Receptor-1 Antagonist F 16618 Reduces Arterial Restenosis by Down-Regulation of Tumor Necrosis Factor α and Matrix Metalloproteinase 7 Expression, Migration, and Proliferation of Vascular Smooth Muscle Cells

Pauline Chieng-Yane, Arnaud Bocquet, Robert Létienne et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 45 citations

Medicine, Cardiology, Pharmacology +11

Protease-Activated Receptor-1 Mediates Thrombin-Induced Persistent Sodium Current in Human Cardiomyocytes

Caroline Pinet, Vincent Algalarrondo, Sylvie Sablayrolles et al. · Molecular Pharmacology · 2008 · 20 citations

Medicine, Cardiology, Physiology +15

3-(R)-[3-(2-Methoxyphenylthio-2-(S)-methylpropyl]amino-3,4-dihydro-2H-1,5-benzoxathiepine Bromhydrate (F 15845) Prevents Ischemia-Induced Heart Remodeling by Reduction of the Intracellular Na+ Overload

Bruno Vié, Sylvie Sablayrolles, Robert Létienne et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 15 citations

Medicine, Cardiology, Pharmacology +11

F 15845, a new blocker of the persistent sodium current prevents consequences of hypoxia in rat femoral artery

Arnaud Bocquet, Sylvie Sablayrolles, Bernard Vacher et al. · British Journal of Pharmacology · 2010 · 14 citations · Full text

Medicine, Cardiology, Pharmacology +16